Featured Research

from universities, journals, and other organizations

Photons vs. protons for treatment of spinal cord gliomas

Date:
December 23, 2010
Source:
Ohio State University Medical Center
Summary:
A study comparing the long-term outcomes of patients with spinal-cord tumors following radiation therapy suggests that certain subsets of patients have better long-term survival, and that photon-based radiation therapy may result in better survival than proton-beam therapy, even in patients with more favorable characteristics.

A study comparing the long-term outcomes of patients with spinal-cord tumors following radiation therapy suggests that certain subsets of patients have better long-term survival. It also suggests that photon-based radiation therapy may result in better survival than proton-beam therapy, even in patients with more favorable characteristics.

Related Articles


This is the first study to report the long-term outcomes of spinal-cord tumor patients treated by modern radiotherapy techniques, the researchers say. Gliomas, which represent most spinal cord tumors, develop in about 17,000 Americans annually, and 13,000 die from them.

"Our findings need to be verified in a larger number of patients, but they suggest that individuals younger than age 54, those with ependymomas and those treated with photon-based therapy versus proton-beam treatment have better overall survival," says principal investigator Dr. Arnab Chakravarti, chair and professor of Radiation Oncology and co-director of the Brain Tumor Program at The Ohio State Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

"Perhaps most surprising is that the subset of spinal-cord tumor patients treated by protons appears to do worse, even though they have more favorable pretreatment demographics," Chakravarti says. "This certainly warrants validation in a larger subset of patients."

Surgery is the standard therapy for spinal-cord tumors, and it is often followed by radiotherapy. But whether all patients or only certain patients should receive radiation therapy is controversial, Chakravarti says.

The research is published in a recent issue of the International Journal of Radiation Oncology, Biology, Physics.

The retrospective study examined the long-term outcomes of 32 patients with primary spinal-cord gliomas. Twenty-two of the patients were treated with photon-beam radiation therapy (such as 3-D conformal radiation and intensity-modulated radiotherapy), and 10 were treated with proton-beam therapy.

The five-year overall survival rate was 65 percent and the progression free survival was 61 percent for the group. The study also showed poorer overall survival for the following patients:

  • Those age 55 and older.
  • Those with astrocytomas versus ependymomas.
  • Those who had a biopsy versus those whose tumor was surgically removed.

Funding from the National Cancer Institute and the Brain Tumor Funders Collaborative Group supported this research..


Story Source:

The above story is based on materials provided by Ohio State University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jenna Kahn, Jay Steven Loeffler, Andrzej Niemierko, E. Antonio Chiocca, Tracy Batchelor, Arnab Chakravarti. Long-Term Outcomes of Patients with Spinal Cord Gliomas Treated by Modern Conformal Radiation Techniques. International Journal of Radiation OncologyBiologyPhysics, 2010; DOI: 10.1016/j.ijrobp.2010.05.009

Cite This Page:

Ohio State University Medical Center. "Photons vs. protons for treatment of spinal cord gliomas." ScienceDaily. ScienceDaily, 23 December 2010. <www.sciencedaily.com/releases/2010/12/101222112225.htm>.
Ohio State University Medical Center. (2010, December 23). Photons vs. protons for treatment of spinal cord gliomas. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2010/12/101222112225.htm
Ohio State University Medical Center. "Photons vs. protons for treatment of spinal cord gliomas." ScienceDaily. www.sciencedaily.com/releases/2010/12/101222112225.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins